Sells cordyceps-based nutritional products.
Jun 2026Revenue $0.00/yrExpenses $209K/yr
No trend
Figures by year
When will Acro Biomedical be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $209K.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $154K | −$154K |
| Dec 2024 | $0.00 | $38.0K | −$38.0K |
| Dec 2023 | $0.00 | $8.80M | −$8.80M |
| Dec 2022 | $659K | $16.5M | −$15.9M |
| Dec 2021 | $1.20M | $8.89M | −$7.69M |
| Dec 2020 | $688K | $818K | −$130K |
| Dec 2019 | $194K | $616K | −$423K |
| Sep 2019 | $1.35M | $1.80M | −$442K |
| Sep 2018 | $8.01M | $7.50M | $516K |
| Sep 2017 | $510K | $512K | −$2.25K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.